Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-24 @ 9:28 PM
NCT ID:
NCT04875832
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of relapsing-remitting or progressive MS.
* Presence of depressive symptomatology, with HADS scores \> 8, confirmed by HDRS scores (clinical interview) \> 14.
* No change of pharmacological treatment in the 3 months before the enrolment.
* Ability to communicate and to understand tasks.
* No clinical relapses or use of steroid treatment during the 4 weeks before the enrolment.
* Provided informed consent for study participation.
Exclusion Criteria:
* Severe co-morbidity that would reduce life expectancy to less than one year (i.e. end-stage oncological diseases or severe cardiac dysfunction).
* Severe neuropsychological impairment evaluated with the MMSE.
* Psychosis or dissociative disorders.
* No current psychotherapy treatment
* Pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04875832
Study Brief:
Protocol Section:
NCT04875832